CR1 and Alzheimer disease: For instance, hypomethylation at CpG island shores (regions flanking CpG-rich promoter sequences that are particularly susceptible to age- and disease-related methylation changes) has been observed at CLU, CR1 and PICALM in the blood of Japanese AD patients [329].